Abbott

Company Snapshot

Founded: 1888
Entity Type: Public
Employees: 114,000
Region: North America
Revenue: $41,950.0 Millions
Revenue Year: 2024
Segment: Established Pharmaceutical Products and Medical Devices
Headquarter: Illinois, U.S.
Key Geographics: U.S., Germany, China, Japan, India, Switzerland, Canada
Corporate Address: 100 Abbott Park Road, Abbott Park, Illinois 60064, U.S. Tel: +1-224-667-6100 Website: www.abbott.com

Company Overview

Abbott is a medical technology company that designs, develops, manufactures, and markets medical devices, diagnostics, nutritional products, and generic medicines. The company operates its business through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The Established Pharmaceutical Products segment portfolios span multiple therapeutic areas, including gastroenterology, women’s health, cardiometabolic, pain management/central nervous system, and respiratory. The Nutritional Products segment offers a wide range of nutritional products to meet children's and adults' different health and dietary needs, infant formula and follow-on formula, adult and other pediatric nutritional products, and nutritional products used in enteral feeding in healthcare institutions.

The diagnostics segment provides various systems and tests that provide comprehensive healthcare solutions. The Medical Devices segment includes products for cardiovascular treatment, diabetes care, and neuromodulation for managing chronic pain and movement disorders.

Abbott sells its products in more than 160 countries globally and has a strong presence in the U.S., Europe, and Asia Pacific.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Abbott In Reports

Noninvasive Cancer Diagnostics: Technologies and Global Markets

According to BCC Research detailed report on noninvasive cancer diagnostic market global revenue ($ Million) for the base year 2024, estimated data for 2025, and forecasts through 2026-2030.

Technologies for Long-Term Care and Home Healthcare: Global Markets

According to BCC Research detailed report on technologies for long-term care and home healthcare market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates through 2030.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Our detailed report on the Central Nervous System Biomarkers Markets is segmented based on by biomarker type, technology, disease, application, and region for the forecast 2025 through 2030.

Company's Business Segments

  • Established Pharmaceutical Products : Gastroenterology, Women’s health, Cardiovascular and metabolic, Pain and central nervous system, and Respiratory drugs and vaccines
  • Nutritional Products : Infant formula and follow-on formula, Adult and other pediatric nutritional, and Nutritional used in enteral feeding in health care institutions
  • Diagnostic Products : Core laboratory and transfusion medicine systems in the areas of immunoassay, Molecular diagnostics polymerase chain reaction (PCR) instrument systems, Point of care systems, Rapid diagnostics lateral flow testing products in the area of infectious diseases such as SARS-CoV-2, and informatics and automation solutions for use in laboratories
  • Medical Devices : Rhythm management, Electrophysiology, Heart failure, Vascular, Structural heart, Continuous glucose and blood glucose monitoring systems, and Neuromodulation

Applications/End User Industries

  • Healthcare Professionals
  • Physicians
  • Pharmacies
  • Pharmacists
  • Laboratory Technicians
  • Public Health Organizations
  • Hospitals
  • Clinics
  • Government Agencies
  • Supermarkets
  • Online Retailers
  • Pharmaceuticals
  • Healthcare
AI Sentiment